Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos et al. · Nature Genetics · 2012
Cited by 1,397 works. doi:10.1038/ng.2396 Open-access PDF
Authors
- Martin Peifer
- Lynnette Fernandez‐Cuesta
- Martin L. Sos
- Julie George
- Danila Seidel
- Lawryn H. Kasper
- Dennis Plenker
- Frauke Leenders
- Ruping Sun
- Thomas Zander
- Roopika Menon
- Mirjam Koker
- Ilona Dahmen
- Vincenzo Di Cerbo
- Hans‐Ulrich Schildhaus
- Janine Altmüller
- Ingelore Baessmann
- Christian Becker
- Bram De Wilde
References
- Fast and accurate short read alignment with Burrows–Wheeler transform
- Mapping short DNA sequencing reads and calling variants using mapping quality scores
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
- Integrated genomic analyses of ovarian carcinoma
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
- SIFT: predicting amino acid changes that affect protein function
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- Somatic mutations affect key pathways in lung adenocarcinoma